Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous methylprednisolone for prevention of post‑operative sore throat after general anesthesia
IRCT20251007067539N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Oct 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of methylprednisolone in Post-extubation sore throat (POST), sponsored by Zahedan University of Medical Sciences. Started Oct 2025; status: completed.
02
Drugs
methylprednisolone
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20251007067539N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251007067539N1.